Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PBLA Panbela Therapeutics Inc

1,11

0,00 (0,00%)

17 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Article too big to display. Click here to view on the SEC website

Panbela Therapeutics (NASDAQ:PBLA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Panbela Therapeutics Charts.

Panbela Therapeutics (NASDAQ:PBLA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Panbela Therapeutics Charts.

News Panbela Therapeutics Inc

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
Dienstag 24 September 2024 (4 Monate vor) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Freitag 16 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Panbela Provides Business Update and Reports Q2 2024 Financial Results
Dienstag 13 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 30 Juli 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 30 Juli 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 3 Juli 2024 (7 Monate vor) • Edgar (US Regulatory)

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
Montag 24 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
Montag 10 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 29 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Panbela Provides Business Update and Reports Q1 2024 Financial Results
Mittwoch 15 Mai 2024 (8 Monate vor) • GlobeNewswire Inc.

Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Montag 6 Mai 2024 (8 Monate vor) • GlobeNewswire Inc.

Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
Mittwoch 1 Mai 2024 (9 Monate vor) • GlobeNewswire Inc.

Weitere Panbela Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen